AMLX

AMYLYX PHARMACEUTICALS INC

AMLX·03237H101·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

AMLX (AMYLYX PHARMACEUTICALS INC) is held by 97 institutional investors as of Q1 2026. Largest holders: FMR LLC ($231.2M), BlackRock, Inc. ($122.7M), Janus Henderson Group Ltd. ($69.3M). Net institutional sentiment: Mixed.

97
Holders
Avg rating(20 Elite)
$959.7M
Total Value
55% (112)
Fund Consensus
58 buying - 47 selling
AMLXSmart Money Verdict
View all
Held by 97 funds
20 elite
Who's Trading
InsiderMGMazzariello GinaSell $264KJul 10, 2026
InsiderMGMazzariello GinaSell $275KJul 9, 2026
InsiderFKFirestone KarenBuy $51KMay 21, 2026
ActivistPAPerceptive Advisors LLC7.5%May 15, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderCBCohen Joshua BSell $424KMar 2, 2026
InsiderKBKlee Justin B.Sell $424KMar 2, 2026
InsiderBLBedrosian Camille LSell $94KMar 2, 2026
InsiderFMFRATES JAMES MSell $115KMar 2, 2026
InsiderMGMazzariello GinaSell $99KMar 2, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
16.6M(+0.7%)$231.2M0.0%+45.06%
31
Decreased
8.8M(-2.5%)$122.7M0.0%+111.22%
0
Increased
5M(+11.7%)$69.3M0.0%+29.75%
33
New
4.1M$57.6M0.0%+25.94%
41
Increased
3.6M(+28.2%)$49.5M0.1%+165.46%
37
Decreased
3M(-3.9%)$41.5M0.3%+64.98%
0
Increased
2.6M(+0.5%)$36.5M0.0%+102.91%
29
Increased
2.4M(+14.2%)$32.8M0.0%+64.65%
33
Increased
2.3M(+88.5%)$31.4M0.0%+36.79%
45
Increased
2.2M(+2.1%)$30.7M0.0%+53.74%
29
Decreased
2.2M(-7.8%)$30.2M0.0%+51.29%
0
Decreased
1.3M(-0.4%)$18.5M0.0%+89.51%
0
Decreased
1.3M(-4.9%)$17.6M0.0%+21.50%
0
Increased
1.1M(+28.9%)$15.4M0.0%+20.70%
35
Increased
971,854(+229.2%)$13.5M0.0%+30.50%
45
New
944,781$13.1M0.0%+25.94%
39
Increased
903,192(+17.1%)$12.5M0.0%+76.92%
33
Decreased
868,325(-13.5%)$12.1M0.0%+201.81%
0
Increased
845,800(+0.1%)$11.8M0.0%+384.72%
28
Decreased
779,908(-16.8%)$10.8M0.0%+95.19%
0

Showing 1-20 of 112

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used